Silvia Rivara

5.9k total citations
136 papers, 4.9k citations indexed

About

Silvia Rivara is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Pharmacology. According to data from OpenAlex, Silvia Rivara has authored 136 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 45 papers in Endocrine and Autonomic Systems and 39 papers in Pharmacology. Recurrent topics in Silvia Rivara's work include Circadian rhythm and melatonin (43 papers), Cannabis and Cannabinoid Research (35 papers) and Receptor Mechanisms and Signaling (33 papers). Silvia Rivara is often cited by papers focused on Circadian rhythm and melatonin (43 papers), Cannabis and Cannabinoid Research (35 papers) and Receptor Mechanisms and Signaling (33 papers). Silvia Rivara collaborates with scholars based in Italy, United States and France. Silvia Rivara's co-authors include Marco Mor, Giorgio Tarzia, Alessio Lodola, Gilberto Spadoni, Daniele Piomelli, Annalida Bedini, Andrea Tontini, Andrea Duranti, Pier Vincenzo Plazzi and Daniele Pala and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Nature Neuroscience.

In The Last Decade

Silvia Rivara

134 papers receiving 4.8k citations

Peers

Silvia Rivara
Silvia Rivara
Citations per year, relative to Silvia Rivara Silvia Rivara (= 1×) peers Jean‐Pierre Maffrand

Countries citing papers authored by Silvia Rivara

Since Specialization
Citations

This map shows the geographic impact of Silvia Rivara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Rivara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Rivara more than expected).

Fields of papers citing papers by Silvia Rivara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Rivara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Rivara. The network helps show where Silvia Rivara may publish in the future.

Co-authorship network of co-authors of Silvia Rivara

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Rivara. A scholar is included among the top collaborators of Silvia Rivara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Rivara. Silvia Rivara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bedini, Annalida, Michele Retini, Laura Scalvini, et al.. (2024). Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence. Journal of Pineal Research. 76(2). e12941–e12941. 3 indexed citations
2.
Okamoto, Hiroyuki, Erika Cecon, Osamu Nureki, Silvia Rivara, & Ralf Jockers. (2024). Melatonin receptor structure and signaling. Journal of Pineal Research. 76(3). e12952–e12952. 18 indexed citations
3.
Scalvini, Laura, Carmine Giorgio, Riccardo Castelli, et al.. (2023). Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity. Journal of Chemical Information and Modeling. 63(21). 6900–6911. 4 indexed citations
4.
Guillou, Catherine, Peter G. Goekjian, Pierre Garcia, et al.. (2022). An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex Formation. Antibiotics. 11(10). 1449–1449. 4 indexed citations
5.
Scalvini, Laura, et al.. (2022). In silico drug discovery of melatonin receptor ligands with therapeutic potential. Expert Opinion on Drug Discovery. 17(4). 343–354. 8 indexed citations
6.
Scalvini, Laura, et al.. (2022). Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency. Journal of Chemical Information and Modeling. 62(11). 2771–2787. 6 indexed citations
7.
Scalvini, Laura, et al.. (2021). Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors. Journal of Chemical Information and Modeling. 62(1). 210–222. 11 indexed citations
8.
Ferlenghi, Francesca, Laura Scalvini, Federica Vacondio, et al.. (2021). A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine. European Journal of Medicinal Chemistry. 225. 113786–113786. 40 indexed citations
9.
Montanari, Serena, Marco Allarà, Laura Scalvini, et al.. (2021). New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators. Molecules. 26(11). 3254–3254. 12 indexed citations
10.
Kinker, Gabriela Sarti, Sandra Márcia Muxel, Itay Tirosh, et al.. (2021). MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression. Journal of Molecular Medicine. 99(2). 289–301. 16 indexed citations
11.
Bedini, Annalida, Laura Scalvini, Caterina Carmi, et al.. (2020). Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria. Molecules. 25(18). 4057–4057. 8 indexed citations
12.
Pala, Daniele, Laura Scalvini, Alessio Lodola, et al.. (2020). New classes of potent heparanase inhibitors from ligand-based virtual screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1685–1696. 11 indexed citations
13.
Scalvini, Laura, Alessio Lodola, Donatella Callegari, et al.. (2020). N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations. ACS Catalysis. 10(20). 11797–11813. 13 indexed citations
14.
Vozella, Valentina, Faizy Ahmed, Collin B. Merrill, et al.. (2019). Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats. Journal of Pharmacy and Pharmacology. 71(12). 1762–1773. 9 indexed citations
15.
Spadoni, Gilberto, Stéphane Bach, Monica Benincasa, et al.. (2019). New Antimicrobials Targeting Bacterial RNA Polymerase Holoenzyme Assembly Identified with an in Vivo BRET-Based Discovery Platform. ACS Chemical Biology. 14(8). 1727–1736. 10 indexed citations
16.
Madia, Valentina Noemi, Antonella Messore, Luca Pescatori, et al.. (2018). Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity. Journal of Medicinal Chemistry. 61(15). 6918–6936. 28 indexed citations
17.
Spadoni, Gilberto, Annalida Bedini, Michele Mari, et al.. (2018). Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit. Journal of Medicinal Chemistry. 61(17). 7902–7916. 22 indexed citations
18.
Diamanti, Eleonora, Daniela Pizzirani, Natalia Realini, et al.. (2017). Synthesis and characterization of the first inhibitor ofN-acylphosphatidylethanolamine phospholipase D (NAPE-PLD). Chemical Communications. 53(95). 12814–12817. 28 indexed citations
19.
Sartori, Andrea, Luca Dell’Amico, Lucia Battistini, et al.. (2013). Synthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylate. Organic & Biomolecular Chemistry. 12(10). 1561–1561. 18 indexed citations
20.
Pietra, Gabriella, Claudia Manzini, Silvia Rivara, et al.. (2012). Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity. Cancer Research. 72(6). 1407–1415. 249 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026